Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03041129 · ClinicalTrials.gov registry record
Post-Prandial Liver Glucose Metabolism in PCOS
A clinical trial, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- 19
- Enrollment target
NCT03041129 is a clinical trial that has completed, run by University of Colorado, Denver. The registered enrollment target is 19 participants.
The verdict
NCT03041129 has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- 19 participants
- Enrollment target
Study Summary
The Investigators will measure if hepatic metabolism is upregulated in obese girls with PCOS and hepatic steatosis (HS), compared to PCOS without HS and obese controls without HS.
Interventions
- DIAGNOSTIC_TEST oral glucose tolerance test
- DIAGNOSTIC_TEST MRI of liver
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2017-04-14 |
| Est. Completion | 2018-09-29 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03041129
The ClinicalTrials.gov registry entry for NCT03041129 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which oral glucose tolerance test is the first listed.
NCT03041129 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03041129 about?
NCT03041129 is a clinical study titled "Post-Prandial Liver Glucose Metabolism in PCOS". The Investigators will measure if hepatic metabolism is upregulated in obese girls with PCOS and hepatic steatosis (HS), compared to PCOS without HS and obese controls without HS.
What is the current status of trial NCT03041129?
This trial is currently completed. The enrollment target is 19 participants. The study started on 2017-04-14. Estimated completion is 2018-09-29.
What interventions are being tested in trial NCT03041129?
The interventions under investigation include: oral glucose tolerance test (DIAGNOSTIC_TEST), MRI of liver (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03041129?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.